Be the first to like this
Unilife announced that it has created a new drug delivery device that has been selected by a top-tier pharmaceutical company for clinical testing of a biological drug. The prototype, which was provided to the customer in April, will support targeted organ delivery of the therapeutic agent. The clinical trial is expected to begin in the fourth quarter 2011 or first quarter of 2012. The identity of the customer, terms of the initial agreement, and the nature of the device are being kept confidential at this time. But the signing of a supply agreement and shipment of the disposable device are expected to occur shortly.